Related Experiment Video

Updated: May 12, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin

Belal Al-Husein1, Anna Goc, Payaningal R Somanath

  • 1Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, Georgia, USA.

Journal of Cellular Physiology
|April 6, 2013
PubMed

Insights

Simvastatin effectively inhibits prostate cancer micrometastasis by blocking cancer cell migration and strengthening the endothelial barrier. This study reveals simvastatin

Area of Science:

  • Oncology
  • Molecular Biology
  • Vascular Biology

Background:

  • Micrometastasis is crucial for cancer spread and requires cancer cell interaction with the endothelium.
  • Targeting micrometastasis offers therapeutic potential for cancer therapy and prevention.
  • Molecular mechanisms of prostate cancer micrometastasis are not fully understood, hindering drug development.

Purpose of the Study:

  • To investigate simvastatin's potential to inhibit prostate cancer micrometastasis.
  • To elucidate the molecular mechanisms underlying simvastatin's anti-micrometastasis effects.

Main Methods:

  • In vitro transendothelial migration assays using PC3 prostate cancer cells.
  • Analysis of angiopoietins and VEGF-A expression (mRNA and protein) in PC3 cells.
  • Assessment of endothelial cell activation and barrier resistance.
  • Evaluation of integrin αv β3 activity and its interaction with ICAM-1.

Main Results:

  • Simvastatin significantly inhibited PC3 cell transendothelial migration.
  • Simvastatin modulated angiopoietin and VEGF-A expression, preventing endothelial-barrier disruption.
  • Simvastatin enhanced endothelial cell activation and barrier resistance.
  • Simvastatin suppressed integrin αv β3 activity and its interaction with endothelial ICAM-1.

Conclusions:

  • Simvastatin demonstrates significant potential in inhibiting prostate cancer micrometastasis.
  • Simvastatin acts through modulating tumor-derived angiogenic factors and directly enhancing endothelial barrier function.
  • Inhibition of integrin αv β3 and its interaction with ICAM-1 are key mechanisms for simvastatin's anti-micrometastasis effects.

More Related Videos

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...